Deals
Ambica is a subsidiary of Bridgeway Pharma, ultimately controlled by United Laboratories.
1
Shareholders of PH pharma firm Ambica International enter stake sale talks
2
Indian VCs turn to Europe, Asia as Mideast LPs raise their guard
3
DeepSeek unveils new AI model tailored for Huawei chips as China pushes for tech autonomy
4
IFC targets $10b in annual investments in India by 2030
5
India's central bank cancels Paytm Payments Bank licence
More Stories
Golden Gate seeks $150m from secondary sale of SE Asian startup stakes
[Updated] IFC, ADB may commit a total of $150m to Growtheum’s second fund
India: PE money flows into diagnostics, bets on consolidation ahead
Exit bottlenecks drag SE Asia PE deal value to $14b in 2025: Bain report
ADB commits $417m to funds, private firms in 2025 in equity push
Analysis
Firms seeking fresh capital may have to shrink their fund sizes.
Most leading AI models are trained and run on chips made by Nvidia.
India is IFC’s largest investment destination globally.
Policy & Regulations
Paytm had obtained a limited banking license in August 2015.
Greater China
The heightened scrutiny follows Meta’s more than $2 billion acquisition of AI startup Manus in 2025.
Vietnam
The listing is tentatively planned for 2028-29 in Vietnam.
India
The acquisition will see Aseem merge into a newly formed joint venture.
Singapore
Anthropic, whose $30b fundraising was led by GIC, plans to open a Singapore office.
Asian PE is increasingly a liquidity engineering business.
